Alnylam Pharmaceuticals competitorsClear all

Alnylam Pharmaceuticals's top competitors include CureVac, Regulus Therapeutics, Reata Pharmaceuticals, Moderna, Ionis Pharmaceuticals, Sorrento Therapeutics, Celyad and Sarepta Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Founding Date
Founding Date
2002
Founding Date
2000
Founding Date
2007
Founding Date
2002
Founding Date
N/A
Founding Date
1989
Founding Date
2006
Founding Date
2007
Founding Date
1980
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
San Diego, US HQ
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Locations
Carlsbad, US HQ
Locations
San Diego, US HQ
San Diego, US
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Employees
Employees
1,32324% increase
Employees
4004% increase
Employees
2462% decrease
Employees
22079% increase
Employees
8309% increase
Employees
7577% decrease
Employees
31019% decrease
Employees
87
Employees
74349% increase
Valuation ($)
Valuation ($)
17.7 b
Valuation ($)
1.5 b
Valuation ($)
22.5 m
Valuation ($)
830.2 m
Valuation ($)
85.2 b
Valuation ($)
4.5 b
Valuation ($)
1.3 b
Valuation ($)
63.3 m
Valuation ($)
6.3 b
Twitter followers
Twitter followers
14.8 k
Twitter followers
7
Twitter followers
813
Twitter followers
1.3 k
Twitter followers
140.8 k
Twitter followers
3.8 k
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
3.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
44
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
19.2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
136.8
Average likes per tweet (last 30 days)
7.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
15.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
302137
Alexa Website Rank
210991
Alexa Website Rank
492239
Alexa Website Rank
569068
Alexa Website Rank
134685
Alexa Website Rank
358001
Alexa Website Rank
210216
Alexa Website Rank
N/A
Alexa Website Rank
181719
Employee Rating
Employee Rating
4.3
Employee Rating
3.5
Employee Rating
2.7
Employee Rating
3.9
Employee Rating
3.9
Employee Rating
3.8
Employee Rating
3.3
Employee Rating
3.5
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$492.9m (FY, 2020)
Revenue (est.)
€12.6m (FY, 2018)
Revenue (est.)
$10m (FY, 2020)
Revenue (est.)
$9m (FY, 2020)
Revenue (est.)
$803.4m (FY, 2020)
Revenue (est.)
$729.3m (FY, 2020)
Revenue (est.)
$40m (FY, 2020)
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
$540.1m (FY, 2020)
Cost of goods
Cost of goods
$78.1m (FY, 2020)
Cost of goods
€22.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$7.9m (FY, 2020)
Cost of goods
$11.9m (FY, 2020)
Cost of goods
N/A
Cost of goods
€515k (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$414.8m (FY, 2020)
Gross profit
(€9.8m) (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
$795.5m (FY, 2020)
Gross profit
$717.3m (FY, 2020)
Gross profit
N/A
Gross profit
€3m (FY, 2017)
Gross profit
N/A
Net income
Net income
($858.3m) (FY, 2020)
Net income
(€74.6m) (FY, 2018)
Net income
($15.7m) (FY, 2020)
Net income
($247.8m) (FY, 2020)
Net income
($747.1m) (FY, 2020)
Net income
($486.8m) (FY, 2020)
Net income
($314.4m) (FY, 2020)
Net income
(€56.4m) (FY, 2017)
Net income
($554.1m) (FY, 2020)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
250 (May, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
240 (FY, 2016)
Patents Issued
100 (Q3, 2018)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
3 (May, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
6 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
24 (FY, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 1.5b
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
$ 468.9m
Total funding raised
$ 1.8b
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

CureVac
HQ
Tübingen, DE
Employees
400↑ 4% increase

CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.

View company
Moderna
HQ
Cambridge, US
Employees
830↑ 9% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company